Commonwealth Equity Services’s CorMedix CRMD Stock Holding History

Commonwealth Equity Services’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.63M	Sell	212,135 -2,725	-1%	-$21.8K	﹤0.01%	2227
2026 Q2	$1.69M	Sell	214,860 -1,544	-0.7%	-$12.2K	﹤0.01%	2277
2026 Q1	$1.47M	Buy	216,404 +102,892	+91%	+$761K	﹤0.01%	2272
2025 Q4	$1.32M	Sell	113,512 -5,261	-4%	-$58.2K	﹤0.01%	2353
2025 Q3	$1.38M	Buy	118,773 +6,202	+6%	+$75K	﹤0.01%	2327
2025 Q2	$1.39M	Sell	112,571 -1,115	-1%	-$12.3K	﹤0.01%	2300
2025 Q1	$700K	Buy	113,686 +2,904	+3%	+$30.1K	﹤0.01%	2759
2024 Q4	$897K	Buy	110,782 +16,030	+17%	+$160K	﹤0.01%	2472
2024 Q3	$766K	Hold	94,752	–	–	﹤0.01%	2547
2024 Q2	$410K	Buy	94,752 +56,963	+151%	+$289K	﹤0.01%	3014
2024 Q1	$160K	Hold	37,789	–	–	﹤0.01%	3695
2023 Q4	$142K	Buy	37,789 +22,800	+152%	+$78.5K	﹤0.01%	3605
2023 Q3	$55K	Sell	14,989 -1,000	-6%	-$3.98K	﹤0.01%	3646
2023 Q2	$63K	Sell	15,989 -10,000	-38%	-$49.5K	﹤0.01%	3633
2023 Q1	$107K	Hold	25,989	–	–	﹤0.01%	3481
2022 Q4	$109K	Buy	25,989 +400	+2%	+$1.42K	﹤0.01%	3402
2022 Q3	$72K	Hold	25,589	–	–	﹤0.01%	3432
2022 Q2	$102K	Buy	+25,589	New	+$95.1K	﹤0.01%	3365
2018 Q3	–	Sell	-5,017	Closed	-$6K	–	2805
2018 Q2	$6K	Buy	5,017 +1,740	+53%	+$2.01K	﹤0.01%	2757
2018 Q1	$2K	Hold	3,277	–	–	﹤0.01%	2709
2017 Q4	$8K	Hold	3,277	–	–	﹤0.01%	2673
2017 Q3	$9K	Hold	3,277	–	–	﹤0.01%	2561
2017 Q2	$7K	Buy	+3,277	New	+$11.2K	﹤0.01%	2515
2016 Q3	–	Sell	-2,018	Closed	-$20K	–	2263
2016 Q2	$20K	Hold	2,018	–	–	﹤0.01%	2200
2016 Q1	$27K	Hold	2,018	–	–	﹤0.01%	2160
2015 Q4	$20K	Buy	+2,018	New	+$23.2K	﹤0.01%	2149

Other funds holding CRMD

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Wingate Wealth Advisors Lexington, Massachusetts $241M AUM 12.37% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

PIP

Palisades Investment Partners Santa Monica, California $344M AUM 44.86% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 25.53% 1-Year Est. Return

Commonwealth Equity Services's CRMD Position: Q3 2026 in Review

Commonwealth Equity Services reduced its CorMedix (CRMD) stake by 1.3% in Q3 2026, selling an estimated $21.8K and leaving 212,135 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2227.

Commonwealth Equity Services first reported a position in CRMD in Q4 2015 and has held it in 26 quarters since. The position peaked at $1.69M in Q2 2026. 51 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.

Commonwealth Equity Services held 212,135 shares of CorMedix worth $1.63M as of Q3 2026.
Commonwealth Equity Services sold 2,725 CorMedix shares in Q3 2026, an estimated $21.8K.
CorMedix made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q3 2026, its #2227 holding.
Commonwealth Equity Services first reported a position in CorMedix in Q4 2015 and has held it in 26 quarters since.
Commonwealth Equity Services's CorMedix position peaked at $1.69M in Q2 2026.
51 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.

Based on Commonwealth Equity Services's 13F filing for Q3 2026, filed 2 Nov 2026.